Intracutaneous Delivery of Varied Dose Volumes of Saline

Completed · Not applicable

Conditions studied: Influenza

In brief

This study will evaluate intracutaneous delivery of 0.1, 0.25 and 0.5 milliliter volumes of saline from the FLUGEN 101.2 investigational microneedle-based device.

Key facts

Study ID

NCT01767337

Run by

FluGen Inc

People needed

24

Starts

2012-12-01

Expected to finish

2012-12-01

Last updated by the study team

2017-08-02

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Able to read and/or understand and sign the Informed Consent form

You may not qualify if…

• Medical history of acute or chronic skin disease
• Active skin allergy or acute skin infection, presence of tattoo(s), scars, sunburn or skin abnormalities at any prospective injection site
• Hirsute at any prospective injection site
• Diabetes
• High levels of anxiety or depression or history of psychosis
• Abuse of alcohol or use of other drugs of abuse including tobacco
• Pregnant or breastfeeding women
• Any medical condition that may interfere with study protocol adherence including completion of study activities
• Foreseeable inability to complete the study as scheduled.

Where it is running

• Accelovance Inc — Melbourne, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.